macromolecule metabolic process (GO:0043170) | 0.83 | 9 | APC, FGFR2, CASP10, IRF1, PIK3CA, ERBB2, KRAS, KLF6, MUTYH |
organic substance metabolic process (GO:0071704) | 0.63 | 9 | APC, FGFR2, CASP10, IRF1, PIK3CA, ERBB2, KRAS, KLF6, MUTYH |
cellular process (GO:0009987) | 0.26 | 9 | APC, FGFR2, CASP10, IRF1, PIK3CA, ERBB2, KRAS, KLF6, MUTYH |
metabolic process (GO:0008152) | 0.58 | 9 | APC, FGFR2, CASP10, MUTYH, PIK3CA, ERBB2, KRAS, KLF6, IRF1 |
primary metabolic process (GO:0044238) | 0.69 | 9 | APC, FGFR2, CASP10, MUTYH, PIK3CA, ERBB2, KRAS, KLF6, IRF1 |
cellular macromolecule metabolic process (GO:0044260) | 0.93 | 8 | APC, FGFR2, MUTYH, PIK3CA, ERBB2, KRAS, KLF6, IRF1 |
cellular metabolic process (GO:0044237) | 0.69 | 8 | APC, FGFR2, MUTYH, PIK3CA, ERBB2, KRAS, KLF6, IRF1 |
regulation of cellular process (GO:0050794) | 0.5 | 8 | APC, FGFR2, CASP10, IRF1, PIK3CA, ERBB2, KRAS, KLF6 |
single-organism cellular process (GO:0044763) | 0.65 | 8 | APC, FGFR2, CASP10, IRF1, PIK3CA, ERBB2, KRAS, KLF6 |
positive regulation of biological process (GO:0048518) | 1.2 | 8 | APC, FGFR2, CASP10, IRF1, PIK3CA, ERBB2, KRAS, KLF6 |
biological regulation (GO:0065007) | 0.39 | 8 | APC, FGFR2, CASP10, IRF1, PIK3CA, ERBB2, KRAS, KLF6 |
regulation of biological process (GO:0050789) | 0.45 | 8 | APC, FGFR2, CASP10, IRF1, PIK3CA, ERBB2, KRAS, KLF6 |
single-organism process (GO:0044699) | 0.48 | 8 | APC, FGFR2, CASP10, IRF1, PIK3CA, ERBB2, KRAS, KLF6 |
positive regulation of cellular process (GO:0048522) | 1.3 | 8 | APC, FGFR2, CASP10, IRF1, PIK3CA, ERBB2, KRAS, KLF6 |
positive regulation of metabolic process (GO:0009893) | 1.74 | 7 | APC, FGFR2, IRF1, PIK3CA, ERBB2, KRAS, KLF6 |
regulation of metabolic process (GO:0019222) | 1.02 | 7 | APC, FGFR2, IRF1, PIK3CA, ERBB2, KRAS, KLF6 |
regulation of signal transduction (GO:0009966) | 1.84 | 7 | APC, CASP10, FGFR2, IRF1, PIK3CA, ERBB2, KRAS |
cellular developmental process (GO:0048869) | 1.82 | 7 | APC, CASP10, FGFR2, IRF1, KRAS, ERBB2, KLF6 |
response to stimulus (GO:0050896) | 1.22 | 7 | APC, MUTYH, PIK3CA, ERBB2, KRAS, KLF6, IRF1 |
regulation of response to stimulus (GO:0048583) | 1.54 | 7 | APC, CASP10, FGFR2, IRF1, PIK3CA, ERBB2, KRAS |
positive regulation of macromolecule metabolic process (GO:0010604) | 1.81 | 7 | APC, FGFR2, IRF1, PIK3CA, ERBB2, KRAS, KLF6 |
regulation of cellular metabolic process (GO:0031323) | 1.07 | 7 | APC, FGFR2, IRF1, PIK3CA, ERBB2, KRAS, KLF6 |
regulation of macromolecule metabolic process (GO:0060255) | 1.08 | 7 | APC, FGFR2, IRF1, PIK3CA, ERBB2, KRAS, KLF6 |
signal transduction (GO:0007165) | 1.28 | 7 | APC, CASP10, FGFR2, IRF1, PIK3CA, ERBB2, KRAS |
cell surface receptor signaling pathway (GO:0007166) | 2.09 | 7 | APC, CASP10, FGFR2, IRF1, PIK3CA, ERBB2, KRAS |
regulation of signaling (GO:0023051) | 1.72 | 7 | APC, CASP10, FGFR2, IRF1, PIK3CA, ERBB2, KRAS |
regulation of cell communication (GO:0010646) | 1.73 | 7 | APC, CASP10, FGFR2, IRF1, PIK3CA, ERBB2, KRAS |
regulation of primary metabolic process (GO:0080090) | 1.08 | 7 | APC, FGFR2, IRF1, PIK3CA, ERBB2, KRAS, KLF6 |
regulation of nitrogen compound metabolic process (GO:0051171) | 1.36 | 7 | APC, FGFR2, IRF1, PIK3CA, ERBB2, KRAS, KLF6 |
cellular response to stimulus (GO:0051716) | 1.97 | 6 | APC, MUTYH, PIK3CA, ERBB2, KLF6, IRF1 |
protein metabolic process (GO:0019538) | 1.45 | 6 | APC, CASP10, FGFR2, KRAS, ERBB2, PIK3CA |
positive regulation of cellular metabolic process (GO:0031325) | 1.81 | 6 | FGFR2, IRF1, KRAS, ERBB2, PIK3CA, KLF6 |
cell differentiation (GO:0030154) | 2.14 | 6 | CASP10, FGFR2, IRF1, KRAS, ERBB2, KLF6 |
regulation of protein metabolic process (GO:0051246) | 1.93 | 6 | APC, FGFR2, IRF1, KRAS, ERBB2, PIK3CA |
positive regulation of protein metabolic process (GO:0051247) | 2.43 | 6 | APC, FGFR2, IRF1, KRAS, ERBB2, PIK3CA |
regulation of gene expression (GO:0010468) | 1.37 | 6 | FGFR2, IRF1, KRAS, ERBB2, PIK3CA, KLF6 |
regulation of nucleobase-containing compound metabolic process (GO:0019219) | 1.43 | 6 | FGFR2, IRF1, KRAS, ERBB2, PIK3CA, KLF6 |
negative regulation of biological process (GO:0048519) | 1.33 | 6 | APC, FGFR2, IRF1, KRAS, ERBB2, PIK3CA |
response to chemical (GO:0042221) | 1.98 | 6 | APC, IRF1, KRAS, ERBB2, PIK3CA, KLF6 |
response to organic substance (GO:0010033) | 2.2 | 6 | APC, IRF1, KRAS, ERBB2, PIK3CA, KLF6 |
negative regulation of cellular process (GO:0048523) | 1.41 | 6 | APC, FGFR2, IRF1, KRAS, ERBB2, PIK3CA |
developmental process (GO:0032502) | 1.36 | 5 | APC, ERBB2, KRAS, FGFR2, PIK3CA |
anatomical structure development (GO:0048856) | 1.58 | 5 | APC, ERBB2, FGFR2, KRAS, PIK3CA |
regulation of phosphate metabolic process (GO:0019220) | 2.35 | 5 | APC, ERBB2, FGFR2, KRAS, PIK3CA |
regulation of cellular biosynthetic process (GO:0031326) | 1.38 | 5 | ERBB2, KRAS, FGFR2, IRF1, KLF6 |
positive regulation of response to stimulus (GO:0048584) | 2.18 | 5 | ERBB2, KRAS, FGFR2, PIK3CA, CASP10 |
cellular biosynthetic process (GO:0044249) | 1.37 | 5 | ERBB2, FGFR2, IRF1, KLF6, PIK3CA |
positive regulation of gene expression (GO:0010628) | 2.35 | 5 | ERBB2, KRAS, FGFR2, IRF1, KLF6 |
cellular response to chemical stimulus (GO:0070887) | 2.57 | 5 | APC, ERBB2, IRF1, KLF6, PIK3CA |
regulation of cell differentiation (GO:0045595) | 2.42 | 5 | APC, ERBB2, KRAS, IRF1, FGFR2 |
cellular component organization or biogenesis (GO:0071840) | 1.22 | 5 | APC, ERBB2, KRAS, FGFR2, PIK3CA |
organic substance biosynthetic process (GO:1901576) | 1.34 | 5 | ERBB2, FGFR2, IRF1, KLF6, PIK3CA |
regulation of cellular macromolecule biosynthetic process (GO:2000112) | 1.46 | 5 | ERBB2, KRAS, FGFR2, IRF1, KLF6 |
cellular component organization (GO:0016043) | 1.24 | 5 | APC, ERBB2, KRAS, FGFR2, PIK3CA |
cellular response to organic substance (GO:0071310) | 2.78 | 5 | APC, KLF6, ERBB2, IRF1, PIK3CA |
regulation of protein modification process (GO:0031399) | 2.32 | 5 | APC, ERBB2, KRAS, FGFR2, PIK3CA |
regulation of molecular function (GO:0065009) | 1.78 | 5 | APC, ERBB2, KRAS, PIK3CA, FGFR2 |
regulation of cell proliferation (GO:0042127) | 2.41 | 5 | APC, ERBB2, KRAS, IRF1, FGFR2 |
multicellular organismal process (GO:0032501) | 1.45 | 5 | APC, IRF1, KRAS, FGFR2, PIK3CA |
biosynthetic process (GO:0009058) | 1.32 | 5 | ERBB2, FGFR2, IRF1, KLF6, PIK3CA |
regulation of catalytic activity (GO:0050790) | 1.97 | 5 | APC, ERBB2, FGFR2, KRAS, PIK3CA |
regulation of biosynthetic process (GO:0009889) | 1.37 | 5 | ERBB2, KRAS, FGFR2, IRF1, KLF6 |
regulation of nucleic acid-templated transcription (GO:1903506) | 1.55 | 5 | ERBB2, KRAS, FGFR2, IRF1, KLF6 |
single-organism developmental process (GO:0044767) | 1.49 | 5 | APC, ERBB2, KRAS, FGFR2, PIK3CA |
response to stress (GO:0006950) | 1.8 | 5 | MUTYH, APC, ERBB2, IRF1, KLF6 |
regulation of RNA biosynthetic process (GO:2001141) | 1.55 | 5 | ERBB2, KRAS, FGFR2, IRF1, KLF6 |
regulation of intracellular signal transduction (GO:1902531) | 2.31 | 5 | ERBB2, KRAS, FGFR2, CASP10, PIK3CA |
regulation of phosphorylation (GO:0042325) | 2.5 | 5 | APC, ERBB2, KRAS, PIK3CA, FGFR2 |
regulation of phosphorus metabolic process (GO:0051174) | 2.35 | 5 | APC, ERBB2, FGFR2, KRAS, PIK3CA |
regulation of cellular protein metabolic process (GO:0032268) | 1.99 | 5 | APC, ERBB2, KRAS, FGFR2, PIK3CA |
single-multicellular organism process (GO:0044707) | 1.78 | 5 | APC, IRF1, KRAS, PIK3CA, FGFR2 |
regulation of RNA metabolic process (GO:0051252) | 1.52 | 5 | ERBB2, KRAS, FGFR2, IRF1, KLF6 |
macromolecule modification (GO:0043412) | 1.73 | 5 | MUTYH, ERBB2, KRAS, FGFR2, PIK3CA |
regulation of transcription, DNA-templated (GO:0006355) | 1.56 | 5 | ERBB2, KRAS, FGFR2, IRF1, KLF6 |
regulation of macromolecule biosynthetic process (GO:0010556) | 1.43 | 5 | ERBB2, KRAS, FGFR2, IRF1, KLF6 |
regulation of protein phosphorylation (GO:0001932) | 2.57 | 5 | APC, ERBB2, FGFR2, KRAS, PIK3CA |
positive regulation of biosynthetic process (GO:0009891) | 2.29 | 4 | ERBB2, FGFR2, IRF1, KLF6 |
immune system process (GO:0002376) | 2.29 | 4 | KLF6, IRF1, KRAS, PIK3CA |
movement of cell or subcellular component (GO:0006928) | 2.61 | 4 | APC, ERBB2, KRAS, PIK3CA |
positive regulation of signaling (GO:0023056) | 2.41 | 4 | ERBB2, KRAS, FGFR2, CASP10 |
cellular nitrogen compound metabolic process (GO:0034641) | 1.22 | 4 | MUTYH, IRF1, KLF6, ERBB2 |
nitrogen compound metabolic process (GO:0006807) | 1.13 | 4 | MUTYH, ERBB2, IRF1, KLF6 |
positive regulation of cellular biosynthetic process (GO:0031328) | 2.3 | 4 | ERBB2, FGFR2, IRF1, KLF6 |
enzyme linked receptor protein signaling pathway (GO:0007167) | 3.24 | 4 | ERBB2, KRAS, FGFR2, PIK3CA |
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169) | 3.54 | 4 | ERBB2, KRAS, FGFR2, PIK3CA |
intracellular signal transduction (GO:0035556) | 2.39 | 4 | ERBB2, KRAS, FGFR2, PIK3CA |
regulation of cell death (GO:0010941) | 2.43 | 4 | APC, KRAS, PIK3CA, CASP10 |
regulation of apoptotic process (GO:0042981) | 2.5 | 4 | APC, KRAS, PIK3CA, CASP10 |
positive regulation of cell communication (GO:0010647) | 2.41 | 4 | ERBB2, KRAS, FGFR2, CASP10 |
organic cyclic compound metabolic process (GO:1901360) | 1.26 | 4 | MUTYH, ERBB2, IRF1, KLF6 |
cellular protein metabolic process (GO:0044267) | 1.63 | 4 | ERBB2, KRAS, FGFR2, PIK3CA |
single-organism metabolic process (GO:0044710) | 1.63 | 4 | ERBB2, KRAS, FGFR2, PIK3CA |
positive regulation of signal transduction (GO:0009967) | 2.5 | 4 | ERBB2, KRAS, FGFR2, CASP10 |
positive regulation of phosphorus metabolic process (GO:0010562) | 2.78 | 4 | ERBB2, KRAS, FGFR2, PIK3CA |
regulation of kinase activity (GO:0043549) | 3.07 | 4 | APC, ERBB2, KRAS, PIK3CA |
phosphate-containing compound metabolic process (GO:0006796) | 2.16 | 4 | ERBB2, KRAS, FGFR2, PIK3CA |
regulation of programmed cell death (GO:0043067) | 2.49 | 4 | APC, KRAS, PIK3CA, CASP10 |
animal organ development (GO:0048513) | 2.53 | 4 | APC, ERBB2, FGFR2, PIK3CA |
regulation of immune system process (GO:0002682) | 2.5 | 4 | ERBB2, KRAS, IRF1, PIK3CA |
positive regulation of catalytic activity (GO:0043085) | 2.4 | 4 | ERBB2, KRAS, FGFR2, PIK3CA |
positive regulation of molecular function (GO:0044093) | 2.23 | 4 | ERBB2, KRAS, FGFR2, PIK3CA |
phosphorylation (GO:0016310) | 2.63 | 4 | ERBB2, KRAS, FGFR2, PIK3CA |
positive regulation of cellular protein metabolic process (GO:0032270) | 2.49 | 4 | ERBB2, KRAS, FGFR2, PIK3CA |
positive regulation of nucleic acid-templated transcription (GO:1903508) | 2.56 | 4 | ERBB2, FGFR2, IRF1, KLF6 |
negative regulation of cell proliferation (GO:0008285) | 3.26 | 4 | APC, ERBB2, IRF1, FGFR2 |
protein phosphorylation (GO:0006468) | 2.89 | 4 | ERBB2, KRAS, FGFR2, PIK3CA |
positive regulation of nucleobase-containing compound metabolic process (GO:0045935) | 2.35 | 4 | ERBB2, FGFR2, IRF1, KLF6 |
positive regulation of phosphate metabolic process (GO:0045937) | 2.78 | 4 | ERBB2, KRAS, FGFR2, PIK3CA |
nucleobase-containing compound metabolic process (GO:0006139) | 1.35 | 4 | IRF1, MUTYH, ERBB2, KLF6 |
regulation of developmental process (GO:0050793) | 2.1 | 4 | ERBB2, FGFR2, IRF1, PIK3CA |
regulation of protein kinase activity (GO:0045859) | 3.15 | 4 | APC, ERBB2, PIK3CA, KRAS |
cellular aromatic compound metabolic process (GO:0006725) | 1.3 | 4 | IRF1, MUTYH, ERBB2, KLF6 |
cellular protein modification process (GO:0006464) | 1.79 | 4 | ERBB2, KRAS, FGFR2, PIK3CA |
protein modification process (GO:0036211) | 1.79 | 4 | ERBB2, KRAS, FGFR2, PIK3CA |
positive regulation of transcription, DNA-templated (GO:0045893) | 2.56 | 4 | ERBB2, FGFR2, IRF1, KLF6 |
regulation of multicellular organismal process (GO:0051239) | 1.87 | 4 | ERBB2, FGFR2, IRF1, PIK3CA |
positive regulation of nitrogen compound metabolic process (GO:0051173) | 2.29 | 4 | ERBB2, FGFR2, IRF1, KLF6 |
positive regulation of intracellular signal transduction (GO:1902533) | 2.95 | 4 | ERBB2, KRAS, FGFR2, CASP10 |
heterocycle metabolic process (GO:0046483) | 1.31 | 4 | IRF1, MUTYH, ERBB2, KLF6 |
nucleic acid metabolic process (GO:0090304) | 1.46 | 4 | MUTYH, ERBB2, IRF1, KLF6 |
positive regulation of phosphorylation (GO:0042327) | 2.9 | 4 | ERBB2, KRAS, FGFR2, PIK3CA |
positive regulation of protein modification process (GO:0031401) | 2.7 | 4 | ERBB2, KRAS, FGFR2, PIK3CA |
positive regulation of RNA metabolic process (GO:0051254) | 2.51 | 4 | ERBB2, FGFR2, IRF1, KLF6 |
regulation of transferase activity (GO:0051338) | 2.88 | 4 | APC, ERBB2, PIK3CA, KRAS |
positive regulation of RNA biosynthetic process (GO:1902680) | 2.54 | 4 | ERBB2, FGFR2, IRF1, KLF6 |
positive regulation of macromolecule biosynthetic process (GO:0010557) | 2.39 | 4 | ERBB2, FGFR2, IRF1, KLF6 |
phosphorus metabolic process (GO:0006793) | 2.15 | 4 | ERBB2, KRAS, FGFR2, PIK3CA |
positive regulation of protein phosphorylation (GO:0001934) | 2.95 | 4 | ERBB2, KRAS, FGFR2, PIK3CA |
negative regulation of metabolic process (GO:0009892) | 1.93 | 3 | APC, IRF1, FGFR2 |
RNA biosynthetic process (GO:0032774) | 1.84 | 3 | ERBB2, IRF1, KLF6 |
positive regulation of kinase activity (GO:0033674) | 3.54 | 3 | ERBB2, KRAS, PIK3CA |
regulation of cell activation (GO:0050865) | 3.53 | 3 | ERBB2, IRF1, PIK3CA |
regulation of cell adhesion (GO:0030155) | 3.27 | 3 | ERBB2, IRF1, PIK3CA |
negative regulation of cellular metabolic process (GO:0031324) | 2.01 | 3 | APC, IRF1, FGFR2 |
regulation of T cell activation (GO:0050863) | 4.05 | 3 | ERBB2, IRF1, PIK3CA |
regulation of cell-cell adhesion (GO:0022407) | 3.79 | 3 | ERBB2, IRF1, PIK3CA |
ERBB2 signaling pathway (GO:0038128) | 6.09 | 3 | ERBB2, KRAS, PIK3CA |
cellular macromolecule biosynthetic process (GO:0034645) | 1.66 | 3 | ERBB2, IRF1, KLF6 |
cell death (GO:0008219) | 3.05 | 3 | IRF1, FGFR2, CASP10 |
regulation of protein serine/threonine kinase activity (GO:0071900) | 3.58 | 3 | APC, ERBB2, KRAS |
organic cyclic compound biosynthetic process (GO:1901362) | 1.66 | 3 | ERBB2, IRF1, KLF6 |
cellular lipid metabolic process (GO:0044255) | 2.92 | 3 | ERBB2, FGFR2, PIK3CA |
nucleic acid-templated transcription (GO:0097659) | 1.91 | 3 | ERBB2, IRF1, KLF6 |
regulation of MAPK cascade (GO:0043408) | 3.22 | 3 | ERBB2, KRAS, FGFR2 |
response to endogenous stimulus (GO:0009719) | 2.79 | 3 | APC, KLF6, KRAS |
regulation of lymphocyte activation (GO:0051249) | 3.73 | 3 | ERBB2, IRF1, PIK3CA |
positive regulation of transferase activity (GO:0051347) | 3.31 | 3 | ERBB2, KRAS, PIK3CA |
phosphatidylinositol-mediated signaling (GO:0048015) | 4.93 | 3 | ERBB2, FGFR2, PIK3CA |
glycerophospholipid metabolic process (GO:0006650) | 4.13 | 3 | ERBB2, FGFR2, PIK3CA |
positive regulation of protein kinase activity (GO:0045860) | 3.61 | 3 | ERBB2, KRAS, PIK3CA |
MAPK cascade (GO:0000165) | 3.91 | 3 | ERBB2, KRAS, FGFR2 |
lipid phosphorylation (GO:0046834) | 5.13 | 3 | ERBB2, FGFR2, PIK3CA |
inositol lipid-mediated signaling (GO:0048017) | 4.91 | 3 | ERBB2, FGFR2, PIK3CA |
phosphatidylinositol phosphorylation (GO:0046854) | 5.19 | 3 | ERBB2, FGFR2, PIK3CA |
positive regulation of transcription from RNA polymerase II promoter (GO:0045944) | 2.81 | 3 | IRF1, FGFR2, KLF6 |
signal transduction by protein phosphorylation (GO:0023014) | 3.79 | 3 | ERBB2, KRAS, FGFR2 |
cell migration (GO:0016477) | 3.12 | 3 | APC, KRAS, PIK3CA |
heterocycle biosynthetic process (GO:0018130) | 1.7 | 3 | ERBB2, IRF1, KLF6 |
positive regulation of cell proliferation (GO:0008284) | 3.01 | 3 | ERBB2, KRAS, FGFR2 |
response to oxygen-containing compound (GO:1901700) | 2.57 | 3 | APC, PIK3CA, KLF6 |
phospholipid metabolic process (GO:0006644) | 3.88 | 3 | ERBB2, FGFR2, PIK3CA |
lipid metabolic process (GO:0006629) | 2.68 | 3 | ERBB2, FGFR2, PIK3CA |
apoptotic process (GO:0006915) | 3.14 | 3 | IRF1, FGFR2, CASP10 |
positive regulation of MAPK cascade (GO:0043410) | 3.57 | 3 | ERBB2, KRAS, FGFR2 |
programmed cell death (GO:0012501) | 3.1 | 3 | IRF1, FGFR2, CASP10 |
cell activation (GO:0001775) | 3.47 | 3 | IRF1, KLF6, PIK3CA |
macromolecule biosynthetic process (GO:0009059) | 1.61 | 3 | ERBB2, IRF1, KLF6 |
phosphatidylinositol metabolic process (GO:0046488) | 4.46 | 3 | ERBB2, FGFR2, PIK3CA |
locomotion (GO:0040011) | 2.91 | 3 | APC, KRAS, PIK3CA |
nucleobase-containing compound biosynthetic process (GO:0034654) | 1.72 | 3 | ERBB2, IRF1, KLF6 |
negative regulation of macromolecule metabolic process (GO:0010605) | 2.01 | 3 | APC, IRF1, FGFR2 |
glycerolipid metabolic process (GO:0046486) | 3.91 | 3 | ERBB2, FGFR2, PIK3CA |
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066) | 4.79 | 3 | ERBB2, FGFR2, PIK3CA |
lipid modification (GO:0030258) | 4.37 | 3 | ERBB2, FGFR2, PIK3CA |
leukocyte differentiation (GO:0002521) | 4.13 | 3 | IRF1, KLF6, CASP10 |
RNA metabolic process (GO:0016070) | 1.59 | 3 | ERBB2, IRF1, KLF6 |
regulation of immune response (GO:0050776) | 2.98 | 3 | IRF1, KRAS, PIK3CA |
cellular nitrogen compound biosynthetic process (GO:0044271) | 1.59 | 3 | ERBB2, IRF1, KLF6 |
regulation of biological quality (GO:0065008) | 1.68 | 3 | IRF1, KRAS, PIK3CA |
regulation of cell cycle (GO:0051726) | 2.93 | 3 | APC, IRF1, FGFR2 |
cell motility (GO:0048870) | 3.02 | 3 | APC, KRAS, PIK3CA |
regulation of leukocyte activation (GO:0002694) | 3.6 | 3 | ERBB2, IRF1, PIK3CA |
regulation of transcription from RNA polymerase II promoter (GO:0006357) | 2.24 | 3 | IRF1, FGFR2, KLF6 |
regulation of multicellular organismal development (GO:2000026) | 2.31 | 3 | ERBB2, IRF1, FGFR2 |
transcription, DNA-templated (GO:0006351) | 1.91 | 3 | ERBB2, IRF1, KLF6 |
cellular response to stress (GO:0033554) | 2.51 | 3 | APC, MUTYH, KLF6 |
organophosphate metabolic process (GO:0019637) | 3.04 | 3 | ERBB2, FGFR2, PIK3CA |
aromatic compound biosynthetic process (GO:0019438) | 1.7 | 3 | ERBB2, IRF1, KLF6 |
regulation of leukocyte cell-cell adhesion (GO:1903037) | 4.01 | 3 | ERBB2, IRF1, PIK3CA |
regulation of growth (GO:0040008) | 3.26 | 3 | ERBB2, FGFR2, PIK3CA |
negative regulation of cell differentiation (GO:0045596) | 3.33 | 3 | ERBB2, IRF1, KRAS |
ERBB signaling pathway (GO:0038127) | 5.36 | 3 | ERBB2, KRAS, PIK3CA |
cytokine-mediated signaling pathway (GO:0019221) | 3.6 | 2 | IRF1, KRAS |
cell development (GO:0048468) | 3.28 | 2 | KRAS, FGFR2 |
regulation of Wnt signaling pathway (GO:0030111) | 3.98 | 2 | APC, FGFR2 |
regulation of neuron apoptotic process (GO:0043523) | 4.47 | 2 | KRAS, PIK3CA |
negative regulation of neuron apoptotic process (GO:0043524) | 4.82 | 2 | KRAS, PIK3CA |
regulation of defense response (GO:0031347) | 3.11 | 2 | IRF1, KRAS |
morphogenesis of an epithelium (GO:0002009) | 4.08 | 2 | KRAS, FGFR2 |
single-organism biosynthetic process (GO:0044711) | 2.8 | 2 | FGFR2, PIK3CA |
negative regulation of cell cycle (GO:0045786) | 3.67 | 2 | APC, IRF1 |
positive regulation of cell adhesion (GO:0045785) | 3.79 | 2 | ERBB2, PIK3CA |
peptidyl-tyrosine modification (GO:0018212) | 4.47 | 2 | ERBB2, FGFR2 |
response to growth factor (GO:0070848) | 4.14 | 2 | APC, ERBB2 |
peptidyl-amino acid modification (GO:0018193) | 2.98 | 2 | ERBB2, FGFR2 |
phosphatidylinositol biosynthetic process (GO:0006661) | 4.94 | 2 | FGFR2, PIK3CA |
system process (GO:0003008) | 2.3 | 2 | KRAS, PIK3CA |
negative regulation of cell death (GO:0060548) | 2.95 | 2 | KRAS, PIK3CA |
regulation of T cell proliferation (GO:0042129) | 4.74 | 2 | ERBB2, IRF1 |
lymphocyte activation (GO:0046649) | 3.96 | 2 | IRF1, KLF6 |
epidermal growth factor receptor signaling pathway (GO:0007173) | 5.72 | 2 | KRAS, PIK3CA |
regulation of epithelial cell proliferation (GO:0050678) | 4.06 | 2 | ERBB2, FGFR2 |
neuron projection guidance (GO:0097485) | 4.43 | 2 | ERBB2, KRAS |
regulation of hemopoiesis (GO:1903706) | 4.0 | 2 | ERBB2, IRF1 |
negative regulation of hemopoiesis (GO:1903707) | 4.96 | 2 | ERBB2, IRF1 |
multi-organism process (GO:0051704) | 2.65 | 2 | IRF1, KRAS |
single organism signaling (GO:0044700) | 3.25 | 2 | KRAS, FGFR2 |
immune response-activating cell surface receptor signaling pathway (GO:0002429) | 4.06 | 2 | KRAS, PIK3CA |
negative regulation of T cell differentiation (GO:0045581) | 6.26 | 2 | ERBB2, IRF1 |
negative regulation of cell adhesion (GO:0007162) | 4.33 | 2 | ERBB2, IRF1 |
regulation of cellular component organization (GO:0051128) | 2.01 | 2 | APC, ERBB2 |
regulation of canonical Wnt signaling pathway (GO:0060828) | 4.26 | 2 | APC, FGFR2 |
positive regulation of GTPase activity (GO:0043547) | 3.28 | 2 | ERBB2, FGFR2 |
negative regulation of biosynthetic process (GO:0009890) | 2.47 | 2 | IRF1, FGFR2 |
regulation of anatomical structure morphogenesis (GO:0022603) | 2.79 | 2 | ERBB2, FGFR2 |
leukocyte activation (GO:0045321) | 3.76 | 2 | IRF1, KLF6 |
negative regulation of gene expression (GO:0010629) | 2.48 | 2 | IRF1, FGFR2 |
morphogenesis of a branching structure (GO:0001763) | 4.71 | 2 | KRAS, FGFR2 |
regulation of mononuclear cell proliferation (GO:0032944) | 4.45 | 2 | ERBB2, IRF1 |
axon guidance (GO:0007411) | 4.44 | 2 | ERBB2, KRAS |
positive regulation of protein serine/threonine kinase activity (GO:0071902) | 4.06 | 2 | ERBB2, KRAS |
negative regulation of nucleobase-containing compound metabolic process (GO:0045934) | 2.55 | 2 | IRF1, FGFR2 |
immune response-regulating signaling pathway (GO:0002764) | 3.72 | 2 | KRAS, PIK3CA |
positive regulation of hydrolase activity (GO:0051345) | 2.91 | 2 | ERBB2, FGFR2 |
immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 3.96 | 2 | KRAS, PIK3CA |
positive regulation of immune system process (GO:0002684) | 2.96 | 2 | KRAS, PIK3CA |
negative regulation of immune system process (GO:0002683) | 3.85 | 2 | ERBB2, IRF1 |
anatomical structure formation involved in morphogenesis (GO:0048646) | 3.01 | 2 | FGFR2, PIK3CA |
positive regulation of cellular component organization (GO:0051130) | 2.68 | 2 | APC, ERBB2 |
tissue development (GO:0009888) | 3.27 | 2 | FGFR2, PIK3CA |
wound healing (GO:0042060) | 5.13 | 2 | ERBB2, KLF6 |
cell cycle arrest (GO:0007050) | 4.69 | 2 | APC, IRF1 |
glycerophospholipid biosynthetic process (GO:0046474) | 4.62 | 2 | FGFR2, PIK3CA |
regulation of neuron death (GO:1901214) | 4.19 | 2 | KRAS, PIK3CA |
negative regulation of neuron death (GO:1901215) | 4.57 | 2 | KRAS, PIK3CA |
organophosphate biosynthetic process (GO:0090407) | 3.67 | 2 | FGFR2, PIK3CA |
regulation of hydrolase activity (GO:0051336) | 2.53 | 2 | ERBB2, FGFR2 |
immune response-activating signal transduction (GO:0002757) | 3.8 | 2 | KRAS, PIK3CA |
Fc receptor signaling pathway (GO:0038093) | 4.45 | 2 | KRAS, PIK3CA |
phospholipid biosynthetic process (GO:0008654) | 4.39 | 2 | FGFR2, PIK3CA |
regulation of response to stress (GO:0080134) | 2.53 | 2 | IRF1, KRAS |
negative regulation of leukocyte activation (GO:0002695) | 4.79 | 2 | ERBB2, IRF1 |
regulation of cell motility (GO:2000145) | 3.16 | 2 | APC, ERBB2 |
response to alcohol (GO:0097305) | 4.58 | 2 | APC, KLF6 |
negative regulation of macromolecule biosynthetic process (GO:0010558) | 2.53 | 2 | IRF1, FGFR2 |
regulation of developmental growth (GO:0048638) | 4.04 | 2 | FGFR2, PIK3CA |
negative regulation of nitrogen compound metabolic process (GO:0051172) | 2.47 | 2 | IRF1, FGFR2 |
response to wounding (GO:0009611) | 4.39 | 2 | ERBB2, KLF6 |
regulation of T cell differentiation (GO:0045580) | 5.07 | 2 | ERBB2, IRF1 |
positive regulation of MAP kinase activity (GO:0043406) | 4.39 | 2 | ERBB2, KRAS |
regulation of MAP kinase activity (GO:0043405) | 3.95 | 2 | ERBB2, KRAS |
signaling (GO:0023052) | 3.25 | 2 | KRAS, FGFR2 |
regulation of microtubule-based process (GO:0032886) | 4.79 | 2 | APC, ERBB2 |
anatomical structure morphogenesis (GO:0009653) | 2.53 | 2 | KRAS, FGFR2 |
regulation of GTPase activity (GO:0043087) | 3.21 | 2 | ERBB2, FGFR2 |
protein autophosphorylation (GO:0046777) | 4.46 | 2 | ERBB2, FGFR2 |
response to organic cyclic compound (GO:0014070) | 3.07 | 2 | KRAS, KLF6 |
negative regulation of T cell activation (GO:0050868) | 5.26 | 2 | ERBB2, IRF1 |
positive regulation of multicellular organismal process (GO:0051240) | 2.49 | 2 | IRF1, FGFR2 |
negative regulation of multicellular organismal process (GO:0051241) | 2.84 | 2 | ERBB2, IRF1 |
cell adhesion (GO:0007155) | 2.82 | 2 | APC, IRF1 |
negative regulation of leukocyte cell-cell adhesion (GO:1903038) | 5.19 | 2 | ERBB2, IRF1 |
negative regulation of cellular biosynthetic process (GO:0031327) | 2.49 | 2 | IRF1, FGFR2 |
glycerolipid biosynthetic process (GO:0045017) | 4.53 | 2 | FGFR2, PIK3CA |
negative regulation of lymphocyte differentiation (GO:0045620) | 6.04 | 2 | ERBB2, IRF1 |
biological adhesion (GO:0022610) | 2.81 | 2 | APC, IRF1 |
cellular response to endogenous stimulus (GO:0071495) | 3.33 | 2 | APC, KLF6 |
cellular response to oxygen-containing compound (GO:1901701) | 3.22 | 2 | KLF6, PIK3CA |
negative regulation of nucleic acid-templated transcription (GO:1903507) | 2.71 | 2 | IRF1, FGFR2 |
cellular response to DNA damage stimulus (GO:0006974) | 3.17 | 2 | APC, MUTYH |
regulation of locomotion (GO:0040012) | 3.12 | 2 | APC, ERBB2 |
negative regulation of transcription, DNA-templated (GO:0045892) | 2.75 | 2 | IRF1, FGFR2 |
proteolysis (GO:0006508) | 2.73 | 2 | APC, CASP10 |
regulation of localization (GO:0032879) | 1.94 | 2 | APC, ERBB2 |
response to oxidative stress (GO:0006979) | 3.9 | 2 | MUTYH, KLF6 |
negative regulation of developmental process (GO:0051093) | 3.17 | 2 | ERBB2, IRF1 |
cellular response to growth factor stimulus (GO:0071363) | 4.27 | 2 | APC, ERBB2 |
positive regulation of epithelial cell proliferation (GO:0050679) | 4.67 | 2 | ERBB2, FGFR2 |
negative regulation of lymphocyte activation (GO:0051250) | 4.95 | 2 | ERBB2, IRF1 |
negative regulation of RNA metabolic process (GO:0051253) | 2.66 | 2 | IRF1, FGFR2 |
regulation of lymphocyte proliferation (GO:0050670) | 4.46 | 2 | ERBB2, IRF1 |
positive regulation of immune response (GO:0050778) | 3.4 | 2 | KRAS, PIK3CA |
regulation of lymphocyte differentiation (GO:0045619) | 4.84 | 2 | ERBB2, IRF1 |
lymphocyte differentiation (GO:0030098) | 4.49 | 2 | IRF1, KLF6 |
system development (GO:0048731) | 2.92 | 2 | ERBB2, PIK3CA |
gland development (GO:0048732) | 4.15 | 2 | FGFR2, PIK3CA |
regulation of ERK1 and ERK2 cascade (GO:0070372) | 4.23 | 2 | ERBB2, FGFR2 |
positive regulation of growth (GO:0045927) | 4.25 | 2 | ERBB2, FGFR2 |
cell projection organization (GO:0030030) | 3.14 | 2 | APC, FGFR2 |
negative regulation of cell activation (GO:0050866) | 4.67 | 2 | ERBB2, IRF1 |
peptidyl-tyrosine phosphorylation (GO:0018108) | 4.48 | 2 | ERBB2, FGFR2 |
homeostatic process (GO:0042592) | 2.61 | 2 | KRAS, PIK3CA |
leukocyte migration (GO:0050900) | 4.19 | 2 | KRAS, PIK3CA |
cell cycle process (GO:0022402) | 2.75 | 2 | APC, IRF1 |
angiogenesis (GO:0001525) | 4.15 | 2 | FGFR2, PIK3CA |
negative regulation of cell-cell adhesion (GO:0022408) | 4.84 | 2 | ERBB2, IRF1 |
pattern specification process (GO:0007389) | 3.79 | 2 | APC, FGFR2 |
cell proliferation (GO:0008283) | 3.23 | 2 | ERBB2, FGFR2 |
negative regulation of cellular macromolecule biosynthetic process (GO:2000113) | 2.6 | 2 | IRF1, FGFR2 |
regulation of leukocyte proliferation (GO:0070663) | 4.4 | 2 | ERBB2, IRF1 |
negative regulation of apoptotic process (GO:0043066) | 3.04 | 2 | KRAS, PIK3CA |
tissue morphogenesis (GO:0048729) | 3.87 | 2 | KRAS, FGFR2 |
negative regulation of programmed cell death (GO:0043069) | 3.02 | 2 | KRAS, PIK3CA |
regulation of innate immune response (GO:0045088) | 3.86 | 2 | IRF1, KRAS |
morphogenesis of a branching epithelium (GO:0061138) | 4.77 | 2 | KRAS, FGFR2 |
Fc-epsilon receptor signaling pathway (GO:0038095) | 4.84 | 2 | KRAS, PIK3CA |
negative regulation of RNA biosynthetic process (GO:1902679) | 2.7 | 2 | IRF1, FGFR2 |
cellular component disassembly (GO:0022411) | 3.52 | 2 | APC, PIK3CA |
phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 5.84 | 2 | FGFR2, PIK3CA |
single-organism organelle organization (GO:1902589) | 2.68 | 2 | KRAS, PIK3CA |
cell-cell signaling (GO:0007267) | 3.35 | 2 | KRAS, FGFR2 |
cell communication (GO:0007154) | 3.04 | 2 | KRAS, FGFR2 |
lipid biosynthetic process (GO:0008610) | 3.49 | 2 | FGFR2, PIK3CA |
organelle organization (GO:0006996) | 2.02 | 2 | KRAS, PIK3CA |
response to abiotic stimulus (GO:0009628) | 2.8 | 2 | IRF1, KRAS |
regulation of cellular component movement (GO:0051270) | 3.08 | 2 | APC, ERBB2 |
regulation of multicellular organism growth (GO:0040014) | 5.48 | 2 | FGFR2, PIK3CA |
negative regulation of leukocyte differentiation (GO:1902106) | 5.3 | 2 | ERBB2, IRF1 |
regulation of leukocyte differentiation (GO:1902105) | 4.26 | 2 | ERBB2, IRF1 |
activation of immune response (GO:0002253) | 3.67 | 2 | KRAS, PIK3CA |
immune effector process (GO:0002252) | 3.58 | 2 | IRF1, PIK3CA |